Over the years, SBIR (Small Business Innovation Research) and STTR (Small Business Technology Transfer) grants have provided more than $1.6B to 4,577 Washington state companies. SBIR/STTR grants can enable companies to take shape, prove the value of their technology, and set the stage for later funding from investors
Washington recipients in 2023 include startups Histone Therapeutics, Phase Genomics and Talus Biosciences. Even Seattle-area biotech giant Seagen, which recently sold to Pfizer for $43 billion, landed SBIR grants in its early days.